NICE guidance in schizophrenia: How generalisable are drug trials?
Aims and method: To test the National Institute for Clinical Excellence (NICE) assertion that characteristics of participants in the majority of clinical drug trials in schizophrenia do not reflect clinical practice. In particular they were concerned about the relative exclusion of women, older adul...
| Autor principal: | |
|---|---|
| Formato: | Journal article |
| Lenguaje: | English |
| Publicado: |
2006
|